Altered tumor growth and metastasis of a T-cell lymphoma in Timp-1 transgenic mice

Blood

Volumn 90, Issue 5, 1997, Pages 1993-2000

  Krüger, Achim ^a   Fata, Jimmie E ^a   Khokha, Rama ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; HOST SUSCEPTIBILITY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL LYMPHOMA; TRANSGENIC MOUSE; TUMOR GROWTH;

EID: 1842331535     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.5.1993     Document Type: Article

References (35)

1. Melief CJM: Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv Cancer Res 58:143, 1992
2. Hanna N, Fidler IJ: Role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst 65:801, 1980
3. Umansky V, Beckhove P, Rocha M, Krüger A, Crocker PR, Schirrmacher V: A role of sialoadhesin-positive tissue macrophages in host resistance to lymphoma metastasis in vivo. Immunology 87:303, 1996
4. Rocha M, Krüger A, Van Rooijen N, Schirrmacher V, Umansky V: Liver endothelial cells participate in T-cell-dependent host resistance to lymphoma metastasis by production of nitric oxide in vivo. Int J Cancer 63:405, 1995
5. McCurley TL, Gay RE, Gay S, Glick AD, Haralson MA, Collins RD: The extracellular matrix in "sclerosing" follicular centre cell lymphomas: An immunohistochemical and ultrastructural study. Hum Pathol 17:930, 1986
6. Kossakowska AE, Urbanski SJ, Edwards DR: Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas. Blood 77:2475, 1991
7. McCurley TL, Gay RE, Gay S, Glick AD, Jones MR, Haralson MA, Collins RD: The extracellular matrix in large-cell lymphomas. A histopathologic, immunohistochemical, and ultrastructural study. Hum Pathol 20:164, 1989
8. Matrisisan LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121, 1990
9. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM: Tissue inhibitor of metalloproteinases (TIMP, AKA EPA): Structure, control of expression and biological functions. Pharmacol Ther 59:329, 1993
10. Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G, Denhardt DT: Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 243:947, 1989
11. Schultz RM, Silberman S, Persly B, Bajkowsko AS, Carmichael DF: Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 48:5539, 1988
12. Alvarez OA, Carmichael DF, DeClerck YA: Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 82:589, 1990
13. Chirivi RG, Garofalo A, Crimmin MJ, Bawden LJ, Stoppacciaro A, Brown PD, Giavazzi R: Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int J Cancer 58:460, 1994
14. Martin DC, Rüther U, Sanchez-Sweatman OH, Orr FW, Khokha R: Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice. Oncogene 13:569, 1996
15. Pals ST, Horst E, Scheper RJ, Meijer CJLM: Mechanisms of human lymphocyte migration and their role in the pathogenesis of disease. Immunol Rev 108:111, 1989
16. Kossakowska AE, Urbanski SJ, Huchcroft SA, Edwards DR: Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa Gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs. Oncol Res 4:233, 1992
17. Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ, Edwards DR: Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol Res 5:19, 1993
18. Krüger A, Umansky V, Rocha M, Hacker HJ, Schirrmacher V, Von Hoegen P: Pattern and load of spontaneous liver metastasis dependent on host immune status studied with a lacZ transduced lymphoma. Blood 84:3166, 1994
19. Krüger A, Schirrmacher V, Von Hoegen P: Scattered micrometastases visualized at the single-cell level: Detection and re-isolation of lacZ-labeled metastasized lymphoma cells. Int J Cancer 58:275, 1994
20. Church GM, Gilbert W: Genomic sequencing. Proc Natl Acad Sci USA 81:1991, 1984
21. Folkman J: Tumor angiogenesis, in Mendelsohn J, Howley PM, Israel MA, Liotta LA (eds): The Molecular Basis of Cancer. Philadelphia, PA, Saunders, 1995, p 206
22. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64:327, 1991
23. Takigawa M, Nishida Y, Suzuki F, Kishi J, Yamashita K, Hayakwa T: Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem Biophys Res Commun 3:1264, 1990
24. Martin DC, Sanchez-Sweatman OH, Ho AT, Inderdeo DS, Khokha R: Timp-1 inhibits proliferation and angiogenesis during SV40 T-antigen-induced tumorigenesis in transgenic mice, (submitted)
25. Johnson MD, Kim HR, Chesler L, Tsao-Wu G, Bouck N, Polverini PJ: Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 160:194, 1994
26. Vlodavsky I, Korner G, Eldor A, Bar-Shavit R, Klagsbrun M, Fuks Z: Extracellular matrix-resident growth factors and enzymes, in Zern MA, Reid LM (eds): Extracellular Matrix. New York, NY, Dekker, 1993, p 463
27. Brunner G, Vettel U, Jobstmann S, Kramer MD, Schirrmacher V: A T-cell related proteinase expressed by T-lymphoma cells activates their endogenous pro-urokinase. Blood 79:2099, 1992
28. Pyke C, Kristensen P, Ralfkiaer E, Eriksen J, Dane K: The plasminogen activation system in human colon cancer: Messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma. Cancer Res 51:4067, 1991
29. Pujade-Lauraine E, Lu H, Mirshahi S, Soria J, Soria C, Bernadou A, Kruithof EK, Lijnen HR, Burtin P: The plasminogen-activator system in ovarian tumors. Int J Cancer 55:27, 1993
30. Eitzman DT, Krauss JC, Shen T, Cui J, Ginsburg D: Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma. Blood 87:4718, 1996
31. Poggi A, Bellelli E, Castelli MP, Marinacci R, Rella C, Erickson LA, Donati MB, Bini A: Reduced Lewis lung carcinoma (3LL) metastases in mice transgenic for human plasminogen activator inhibitor-1 (PAI-1). Proc Annu Meet Am Assoc Cancer Res 34:A430, 1993 (abstr)
32. Krüger A, Sanchez-Sweatman OH, Martin DC, Orr W, Rüther U, Khokha R: Host TIMP-1 overexpression confers resistance to experimental brain metastasis. (submitted)
33. Khokha R, Zimmer MJ, Graham CH, Lala PK, Waterhouse P: Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. J Natl Cancer Inst 84:1017, 1992
34. Khokha R: Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst 86:299, 1994
35. DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM: Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52:701, 1992